Literature DB >> 11849313

Signalling pathways induced by protease-activated receptors and integrins in T cells.

Rachel Bar-Shavit1, Miriam Maoz, Yin Yongjun, Maya Groysman, Idit Dekel, Shulamit Katzav.   

Abstract

Recent characterization of the thrombin receptor indicates that it plays a role in T-cell signalling pathways. However, little is known regarding the signalling events following stimulation of additional members of the protease-activated receptor (PAR) family, i.e. PAR2 and PAR3. Most of the postligand cascades are largely unknown. Here, we illustrate that in Jurkat T-leukaemic cells, activation of PAR1, PAR2 and PAR3 induce tyrosine phosphorylation of Vav1. This response was impaired in Jurkat T cells deficient in p56lck (JCaM1.6). Activation of PARs also led to an increase in tyrosine phosphorylation of ZAP-70 and SLP-76, two key proteins in T-cell receptor (TCR) signalling. We also demonstrated that p56lck is meaningful for integrin signalling. Thus, JCaM1.6 cells exhibited a marked reduction in their adherence to fibronectin-coated plates, as compared to the level of adherence of Jurkat T cells. While the phosphorylation of Vav1 in T cells is augmented following adhesion, no additional increase was noted following treatment of the adhered cells with PARs. Altogether, we have identified key components in the postligand-signalling cascade of PARs and integrins. Furthermore, we have identified Lck as a critical and possibly upstream component of PAR-induced Vav1 phosphorylation, as well as integrin activation, in Jurkat T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849313      PMCID: PMC1782632          DOI: 10.1046/j.0019-2805.2001.01351.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  56 in total

Review 1.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.

Authors:  B P Liu; K Burridge
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Vav family proteins couple to diverse cell surface receptors.

Authors:  S L Moores; L M Selfors; J Fredericks; T Breit; K Fujikawa; F W Alt; J S Brugge; W Swat
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Adhesion to fibronectin promotes the activation of the p125(FAK)/Zap-70complex in human T cells.

Authors:  A Bearz; G Tell; S Formisano; S Merluzzi; A Colombatti; C Pucillo
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

5.  Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets.

Authors:  S J Briddon; S P Watson
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

6.  Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn.

Authors:  M F Denny; B Patai; D B Straus
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 7.  Beta 1-integrin-mediated cell signaling in T lymphocytes.

Authors:  S Iwata; Y Ohashi; K Kamiguchi; C Morimoto
Journal:  J Dermatol Sci       Date:  2000-06       Impact factor: 4.563

8.  Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav.

Authors:  M López-Lago; H Lee; C Cruz; N Movilla; X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  Regulation of beta 1 integrin-mediated adhesion by T cell receptor signaling involves ZAP-70 but differs from signaling events that regulate transcriptional activity.

Authors:  J A Epler; R Liu; H Chung; N C Ottoson; Y Shimizu
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

10.  PAR3 is a cofactor for PAR4 activation by thrombin.

Authors:  M Nakanishi-Matsui; Y W Zheng; D J Sulciner; E J Weiss; M J Ludeman; S R Coughlin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

View more
  9 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

2.  Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes.

Authors:  Thati Madhusudhan; Hongjie Wang; Beate K Straub; Elisabeth Gröne; Qianxing Zhou; Khurrum Shahzad; Sandra Müller-Krebs; Vedat Schwenger; Bruce Gerlitz; Brian W Grinnell; John H Griffin; Jochen Reiser; Hermann-Josef Gröne; Charles T Esmon; Peter P Nawroth; Berend Isermann
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

3.  Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.

Authors:  Kristina K Hansen; Mahmoud Saifeddine; Morley D Hollenberg
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

4.  Importance of mast cell Prss31/transmembrane tryptase/tryptase-γ in lung function and experimental chronic obstructive pulmonary disease and colitis.

Authors:  Philip M Hansbro; Matthew J Hamilton; Michael Fricker; Shaan L Gellatly; Andrew G Jarnicki; Dominick Zheng; Sandra M Frei; G William Wong; Sahar Hamadi; Saijun Zhou; Paul S Foster; Steven A Krilis; Richard L Stevens
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

5.  A role for proteinase-activated receptor-1 in inflammatory bowel diseases.

Authors:  Nathalie Vergnolle; Laurie Cellars; Andrea Mencarelli; Giovanni Rizzo; Sunita Swaminathan; Paul Beck; Martin Steinhoff; Patricia Andrade-Gordon; Nigel W Bunnett; Morley D Hollenberg; John L Wallace; Giuseppe Cirino; Stefano Fiorucci
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model.

Authors:  Laetitia Aerts; Marie-Ève Hamelin; Chantal Rhéaume; Sophie Lavigne; Christian Couture; Woojin Kim; Delia Susan-Resiga; Annik Prat; Nabil G Seidah; Nathalie Vergnolle; Beatrice Riteau; Guy Boivin
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

7.  Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells.

Authors:  Satish Ranjan; Alexander Goihl; Shrey Kohli; Ihsan Gadi; Mandy Pierau; Khurrum Shahzad; Dheerendra Gupta; Fabian Bock; Hongjie Wang; Haroon Shaikh; Thilo Kähne; Dirk Reinhold; Ute Bank; Ana C Zenclussen; Jana Niemz; Tina M Schnöder; Monika Brunner-Weinzierl; Thomas Fischer; Thomas Kalinski; Burkhart Schraven; Thomas Luft; Jochen Huehn; Michael Naumann; Florian H Heidel; Berend Isermann
Journal:  Nat Commun       Date:  2017-08-21       Impact factor: 14.919

8.  The role of protease-activated receptor 1 signaling in CD8 T cell effector functions.

Authors:  Hui Chen; Mindy Smith; Jasmin Herz; Tong Li; Rebecca Hasley; Cecile Le Saout; Ziang Zhu; Jie Cheng; Andres Gronda; José A Martina; Pablo M Irusta; Tatiana Karpova; Dorian B McGavern; Marta Catalfamo
Journal:  iScience       Date:  2021-10-30

9.  Transcriptome Analysis and Emerging Driver Identification of CD8+ T Cells in Patients with Vitiligo.

Authors:  Qiancheng Deng; Jingchao Wei; Puyu Zou; Yangfan Xiao; Zhuotong Zeng; Yaqian Shi; Yi Zhan; Huiming Zhang; Bingsi Tang; Qinghai Zeng; Rong Xiao
Journal:  Oxid Med Cell Longev       Date:  2019-11-26       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.